IVL-BioFluidic™: Enabling Ultra-High-Concentration Biologic Formulations Through Microfluidic Engineering

Session details:

• Understand the principles of IVL-BioFluidic™ technology for developing microparticle suspension-based ultra-concentrated formulations of biologics, and how it addresses the challenges associated with high-dose biologic delivery.
• Review the key experimental findings that demonstrate the feasibility and translational potential of the IVL-BioFluidic™ platform for biologic drug delivery.